Ayerst shutdown demonstrates some patent problems with compulsory licensing.
D002170:Canada; D004345:Drug Industry / Q000592:standards*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence; D008004:Licensure; D010330:Patents as Topic